Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.49 USD | +0.37% | +3.19% | +12.47% |
Apr. 29 | Transcript : Capricor Therapeutics, Inc. - Special Call | |
Apr. 24 | Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.47% | 172M | |
+8.56% | 105B | |
-0.97% | 104B | |
+5.44% | 22.94B | |
-12.33% | 22.34B | |
-6.36% | 19.25B | |
-39.98% | 17.08B | |
-8.90% | 16.96B | |
+7.51% | 14.16B | |
+39.63% | 12.63B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Transcript : Capricor Therapeutics, Inc., Q4 2023 Earnings Call, Feb 29, 2024